-80%

est. 2Y upside i

HealthcareSeries A

Tech-powered women's wellness.

Rank

#3613

Sector

Femtech, Wearable Technology, Digital Health

Est. Liquidity

~3Y

Data Quality

Data: Medium

Bellabeat operates in the rapidly growing femtech and wearable markets, with recent product innovations and a clear focus on women's health.

Last updated: March 10, 2026

Bull (10%)+200%

Bellabeat successfully leverages its AI-powered health assistant and IVY+ tracker to significantly expand its subscription base and device sales, achieving over $100M in revenue by 2028. This strong growth and differentiated focus on women's holistic wellness justifies a 5x revenue multiple, leading to a $500M+ valuation and a successful IPO or acquisition.

Base (45%)+40%

Bellabeat maintains its niche in the femtech wearable market, growing revenue to approximately $50M by 2028 through steady device sales and subscription growth. Despite strong incumbent competition, its brand loyalty and specialized offerings allow for a modest valuation increase to around $250M, potentially through a strategic acquisition.

Bear (45%)-60%

Dominant incumbents like Apple and Google (Fitbit) intensify their focus on women's health features, commoditizing Bellabeat's core offerings. Growth stalls, and the company struggles to raise further capital, leading to a down round or acquisition at a significantly reduced valuation of $70M, resulting in a near wipeout for common stock holders due to substantial liquidation preferences.

Est. time to liquidity~2.5 years

Preference Stack Risk

severe

Investors hold $68.3M in liquidation preferences ahead of common stock on an estimated $175M valuation.

Dilution Risk

high

As a Series C company aiming for an IPO, further dilution is possible if the IPO is delayed or if additional capital is required to scale.

Secondary Liquidity

limited

Platforms like Equitybee offer limited secondary liquidity for employee stock options, but no formal company-led secondary market or tender offers are indicated.

Questions to Ask at the Interview

Strategic questions based on Bellabeat's data — designed to show you've done your homework.

  • 1

    “Given the intense competition from Apple and Google (Fitbit) in the broader wearables market, how does Bellabeat plan to sustain and grow its market share specifically within the women's health niche over the next 2-3 years?”

  • 2

    “With current revenue at approximately $35M and a Series C funding round in 2022, what are the company's specific revenue growth targets and key strategies to achieve them, particularly for the subscription-based Bellabeat+ Membership?”

  • 3

    “Considering the company's stated IPO intentions and the Series C funding, what is the realistic timeline for a liquidity event, and how is Bellabeat planning to manage potential dilution for employees holding common stock or options?”

Community

Valuation Sentiment

Our model estimates -80% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.